RxDoctor Payments Data

David Denmark, MD

Interventional Cardiology · South Weymouth, MANPI 1790808814

Payments from drug & device makers

$978in general payments, 2019–2025

Across 19 payments — averaging $51.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$265
  • Bard Peripheral Vascular, Inc.$200
  • Cathworks, Inc.$139
  • Biotronik Inc.$116
  • Veryan Medical Incorporated$106
  • Shockwave Medical, Inc$92
  • plus $59 from 2 others

What the payments were for

  • Food & beverage$978100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$978 in reported general payments places this provider in the 20th percentile of 128 interventional cardiology providers in Massachusetts.

See all interventional cardiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$395,035
Medicare patients
2,495
Services billed
5,184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban272$366,327
EntrestoSacubitril/Valsartan123$188,394
XareltoRivaroxaban73$94,832
JardianceEmpagliflozin48$69,129
BrilintaTicagrelor58$55,608
Atorvastatin Calcium411$7,499
Metoprolol Succinate389$7,140
Diltiazem 24hr Er (Cd)Diltiazem Hcl94$4,047
Midodrine Hcl32$3,968
Rosuvastatin Calcium64$3,063
Ezetimibe31$2,120
ClopidogrelClopidogrel Bisulfate117$1,799
Isosorbide Mononitrate ErIsosorbide Mononitrate84$1,569
Amiodarone Hcl27$1,493
Losartan Potassium73$1,250

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in South Weymouth

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →